CADL
Candel Therapeutics Inc
NASDAQ: CADL · HEALTHCARE · BIOTECHNOLOGY
$6.18
-0.32% today
Updated 2026-04-29
Market cap
$476.11M
P/E ratio
—
P/S ratio
436.42x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$4 – $8
Volume
1.6M
Candel Therapeutics Inc (CADL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |